CAMH welcomes Ontario's narcotics strategy to address inappropriate use of prescription opioids

NewsGuard 100/100 Score

The Government of Ontario's narcotics strategy will address the root causes of a significant and growing health problem - the inappropriate use of prescription opioids.  The Centre for Addiction and Mental Health (CAMH) welcomes the strategy announced by The Honourable Deb Matthews, Minister of Health and Long-Term Care.

"Everyday at CAMH we see the consequences of problematic use of prescription opioids, as more and more people are seeking treatment for opioid dependence," said Dr. Catherine Zahn, CEO of CAMH, Canada's largest teaching hospital for addictions and mental health. "The Minister is committed to both improved treatment and to preventing the problematic use of opioids."

The Minister unveiled her Government's narcotics strategy in London earlier today. The strategy includes a commitment to increased awareness of the risks of prescription narcotics, and legislation to enable far more effective tracking of prescribing and use of prescription opioids and other controlled substances.

"This is not a problem that can be solved overnight," said Dr. Zahn. "But the Minister's strategy contains the key elements of a comprehensive solution: more and better drug information, improved professional and patient education, and high-quality treatment for those with dependence problems."

CAMH population surveys have documented the increasing misuse of prescription drugs. Research released last year indicates that prescription opioids are the third most widely used substance among young people, after alcohol and cannabis. About 18% of students (grades 7 to 12) report using prescription opioids non-medically in the past year, representing 180,000 Ontario students. The source for these drugs was overwhelmingly the students' own homes.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pain reliever use in pregnancy shows no link to child neurodevelopmental disorders, study finds